Pharmaceutical company Moderna announced that its lead vaccine candidate is nearly 95% effective based on an early analysis from an independent board.
“This is a pivotal moment in the development of our COVID-19 vaccine candidate,” Moderna CEO Stephane Bancel said on Monday. “This milestone is only possible because of the hard work and sacrifices of so many.”
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
